Related Experiment Video
Updated: Jan 30, 2026

Isolation of Valvular Endothelial Cells
Published on: December 29, 2010
Potential Role of H-Ferritin in Mitigating Valvular Mineralization
Katalin Éva Sikura1,2, László Potor1,2, Tamás Szerafin2,3
1From the HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian, Academy of Sciences, Debrecen (K.É.S., L.P., M.O., N.P., G.B., J.B.), Faculty of Medicine, University of Debrecen, Hungary.
Insights
Iron metabolism, specifically H-ferritin, mitigates calcific aortic valve disease by preventing mineralization and inflammation. Inducing H-ferritin may offer a novel therapeutic approach for valvular mineralization.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Mineral Metabolism
Background:
- Calcific aortic valve disease (CAVD) is prevalent in the elderly and those with chronic kidney disease.
- The role of iron metabolism in CAVD pathogenesis remains incompletely understood.
- Valvular interstitial cells (VICs) are key players in aortic valve mineralization.
Purpose of the Study:
- To investigate the role of iron metabolism, particularly H-ferritin, in the pathogenesis of CAVD.
- To explore the therapeutic potential of modulating iron metabolism in CAVD.
Main Methods:
- Cultured VICs from stenotic aortic valves were treated with phosphate to induce mineralization.
- H-ferritin induction was assessed via biochemical assays and gene/protein expression analysis.
- Phosphate uptake, pyrophosphate generation, and transcription factor activity (RUNX2, Sox9) were measured.
- In vivo effects were studied using a mouse model and histological analysis of human valves.
- The ferroxidase activity of H-ferritin was evaluated using ceruloplasmin.
Main Results:
- Phosphate induced mineralization and osteoblastic transdifferentiation in VICs.
- Iron, via H-ferritin induction, abrogated phosphate-induced mineralization by reducing phosphate uptake and cellular accumulation.
- H-ferritin decreased alkaline phosphatase (ALP) and osteocalcin secretion, repressed phosphate transporters (Pit1, Pit2), and reduced nuclear RUNX2 accumulation.
- H-ferritin enhanced nuclear Sox9 localization and increased pyrophosphate generation via ENPP2 upregulation.
- Treatment with 3H-1,2-dithiole-3-thione mimicked these effects by inducing H-ferritin.
- Histological analysis showed high H-ferritin expression in non-calcified regions of stenotic valves, correlating with reduced inflammation (TNF-α, IL-1β).
Conclusions:
- H-ferritin plays a protective role against valvular mineralization and osteoblastic differentiation in CAVD.
- Ferritin's ferroxidase activity is crucial for its inhibitory function.
- Inducing H-ferritin expression, potentially with agents like 3H-1,2-dithiole-3-thione, represents a promising therapeutic strategy for CAVD.
Abstract:
Objective- Calcific aortic valve disease is a prominent finding in elderly and in patients with chronic kidney disease. We investigated the potential role of iron metabolism in the pathogenesis of calcific aortic valve disease. Approach and Results- Cultured valvular interstitial cells of stenotic aortic valve with calcification from patients undergoing valve replacement exhibited significant susceptibility to mineralization/osteoblastic transdifferentiation in response to phosphate. This process was abrogated by iron via induction of H-ferritin as reflected by lowering ALP and osteocalcin secretion and preventing extracellular calcium deposition. Cellular phosphate uptake and accumulation of lysosomal phosphate were decreased. Accordingly, expression of phosphate transporters Pit1 and Pit2 were repressed. Translocation of ferritin into lysosomes occurred with high phosphate-binding capacity. Importantly, ferritin reduced nuclear accumulation of RUNX2 (Runt-related transcription factor 2), and as a reciprocal effect, it enhanced nuclear localization of transcription factor Sox9 (SRY [sex-determining region Y]-box 9). Pyrophosphate generation was also increased via upregulation of ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase-2). 3H-1, 2-dithiole-3-thione mimicked these beneficial effects in valvular interstitial cell via induction of H-ferritin. Ferroxidase activity of H-ferritin was essential for this function, as ceruloplasmin exhibited similar inhibitory functions. Histological analysis of stenotic aortic valve revealed high expression of H-ferritin without iron accumulation and its relative dominance over ALP in noncalcified regions. Increased expression of H-ferritin accompanied by elevation of TNF-α (tumor necrosis factor-α) and IL-1β (interleukin-1β) levels, inducers of H-ferritin, corroborates the essential role of ferritin/ferroxidase via attenuating inflammation in calcific aortic valve disease. Conclusions- Our results indicate that H-ferritin is a stratagem in mitigating valvular mineralization/osteoblastic differentiation. Utilization of 3H-1, 2-dithiole-3-thione to induce ferritin expression may prove a novel therapeutic potential in valvular mineralization.
Related Concept Videos
Water and Mineral Acquisition
Minerals
Major...
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
The Roles of Bacteria and Fungi in Plant Nutrition
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Mineral, Vitamin and Water Absorption

